Orchestra Biomed Holdings, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
RTW Investments, LP and affiliated funds have increased their beneficial ownership in Orchestra Biomed Holdings, Inc. to 19.2% following the cashless exercise of pre-funded warrants.
NASDAQ
RTW Investments and its affiliated funds have increased their beneficial ownership in Orchestra BioMed Holdings, Inc. to 19.7% by raising the maximum percentage under pre-funded warrants.
NASDAQ
RTW Investments and its affiliated funds increased their beneficial ownership in Orchestra BioMed Holdings, Inc. to 15.4% through the purchase of pre-funded warrants in a public offering.
NASDAQ
SCHEDULE 13D/A: RTW Investments Boosts Stake in Orchestra Biomed to 21.7% Through Recent Open Market Purchases
RTW Investments, LP and its affiliated funds have increased their beneficial ownership in Orchestra Biomed Holdings, Inc. to 21.7% through recent open market purchases.